GGTI-286 | Interleukin Related interleukin-related.com

Product Name :
GGTI-286

Search keywords :
GGTI-286

drugId :
null

Target Vo:
Enzymes

Target Vo Short Name :
Enzymes

Moa_Name:
Enzymes inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-JNK1 (Thr183/Tyr185) Rabbit mAb Epigenetic Reader Domain
Nanog Rabbit mAb supplier
PP2A alpha + beta Antibody: PP2A alpha + beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to PP2A alpha + beta. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts